Painless Nav1.7 mutations reveal function-critical residuesin the outer vestibule and N-terminus
Nivedita SarveswaraniD, Ichrak DrissiiD, Samiha S. ShaikhiD, Mike Nahorski, Fiona S. Cusdin, John E. LinleyiD, Geoff WoodsiD
Abstract
Chronic pain is a common condition, placing a large cost on society and a heavy burden on the individual. Nav1.7 has emerged as a non-redundant and axiomatically important part of human pain pathways. Biallelic loss-of-function (LOF) mutations in SCN9A, encoding voltage-gated sodium channel Nav1.7, cause the Mendelian disorder Congenital Insensitivity to Pain (CIP). Studying novel missense mutations in this channel has the potential to uncover unrealised functions of critical residues that could enable new strategies for analgesia. Here we describe detailed functional studies of six SCN9A missense variants found in individuals with typical SCN9A-CIP: c.224T>C/p.Leu75Pro, c.1025C>T/p.Thr342Met, c.2686C>T/p.Arg896Trp, c.2732G>A/p.Arg911His, c.5059G>C/p.Ala1687Pro, and c.5173G>C/p.Gly1725Arg. While all variants were extremely rare and predicted to alter function, current tools cannot specify the extent or direction of change in function, nor provide information about the mechanism(s) of pathogenicity. Stable cell lines were generated for each variant, using the isogenic Jump-In T-REx HEK293 system. We investigated how each variant caused molecular dysfunction using multiple approaches: sequence conservation analysis and 3D modelling to examine the structural importance of the affected residues; automated whole-cell patch clamp electrophysiology to assess channel biophysics; and finally, immunocytochemistry along with cell-surface biotinylation to detect any alterations in subcellular localisation. Our studies revealed that all mutations reached the cell membrane but caused a complete LOF through small localised structural changes in the extracellular vestibule, ion selectivity filter and N-terminus that abolished sodium conductance. Functional analysis remains the most reliable method of classifying SCN9A missense variants and can help to pinpoint important subdomains. Online SummaryVoltage-gated sodium channel Nav1.7 is a key modulator of nociceptor excitability and associated with congenital painlessness. Functional analysis and in silico modelling reveal critical roles for residues in the extracellular vestibule, ion selectivity filter and unexpectedly, the N-terminus.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Outer Pore Collapse as a Potential Mechanism of Partial Loss of Pain in Nav1.7 M899I
Vishal Sudha Bhagavath Eswaran, Estefania Torres-Ortiz, … Angelika Lampert·bioRxiv·Aug 21, 2026
- Carriers of SCN9A variants linked to inherited and acquired pain syndromes show no alteration in the prevalence of pain or analgesic usage in the UK Biobank cohort
Graeme W. T. Newton, Corin Charman, … Anthony Edward Pickering·medRxiv·Mar 12, 2025
- Identification and targeting of a unique NaV1.7 domain driving chronic pain
Kimberly Gómez, Harrison J. Stratton, … Rajesh Khanna·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 27, 2023
- Uncoupling sodium channel dimers rescues phenotype of pain-linked Nav1.7 mutation
Annika H. Rühlmann, Jannis Körner, … Angelika Lampert·British Journal of PharmacologyPeer-reviewed·Jul 14, 2020
- On the role of Nav1.7 sodium channels in chronic pain: an experimental and computational study
Alberto Capurro, Jack R. Thornton, … Evelyne Sernagor·bioRxiv·Aug 19, 2020
- Discovery of a Selective, State-Independent Inhibitor of NaV1.7 by Modification of Guanidinium Toxins
Hassan Pajouhesh, Jacob T. Beckley, … John V. Mulcahy·Scientific ReportsPeer-reviewed·Sep 9, 2020